Ian Reed is a Scottish born American businessman who leads Pfizer, the world’s largest pharmaceutical company. He was appointed the CEO in 2010 after spending more than two decades at Pfizer in various capacities. Besides heading up the biggest drugmaker on the globe, Read has set the industry talking about his plans to streamline Pfizer.
His back-to-pharma-basics strategy has won fans in the investment community, and analysts are hoping for more spinoffs and breakups, if not at Pfizer, then perhaps at Johnson & Johnson (J&J) or another diversified Big Pharma company.
He also serves on the Boards of Pharmaceutical Research and Manufacturers of America (PhRMA), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the Partnership of New York City.